Special Populations: Heart Failure In patients with both obesity and heart failure with preserved ejection fraction (HFpEF), semaglutide's cardiovascular benefits appear particularly robust
Front Endocrinol 15:1330936 Sagarino T, Luciano S (2024) CO205 impact of GLP-1A treatment on eating disorder incidence: a comparative, real world data study in patients with and without pre-existing mental health conditions
BPC-157 is a short chain of amino acids originally identified in gastric juices, often described as a body repair signal that helps coordinate the protection and renewal of tissues throughout the gut and beyond
It shifts glucose metabolism from glycolysis to glycogen storage and enhances the transport of long chain fatty acids into the mitochondria where they are oxidized for energy production
The authors hypothesized that semaglutide improved steatosis by increasing FA -oxidation and by decreasing hepatic glucose uptake and ER stress and that it improved inflammation by affecting the cytokine and adipokine profile [30]
Retatrutide may be stronger for weight loss based on trial results so far, but Mounjaro is currently the better treatment option for most eligible UK patients because it is approved and available